Novel clinical approaches in monoclonal antibody-based management in colorectal cancer patients: Radioimmunoguided surgery and antigen augmentation
- 11 December 1998
- journal article
- review article
- Published by Wiley in Seminars in Surgical Oncology
- Vol. 15 (4) , 254-262
Abstract
Surgery, the most effective treatment for colon and rectal cancer, is based on empirical knowledge of the patterns of tumor spread, gross findings at laparotomy, and histologic confirmation of tumor‐free margins. In spite of the many technical improvements in surgery, there has not been a significant change in cure rates for colon and rectal cancers. In fact, one‐half of affected patients will not survive 5 years. It is in this arena of treatment for primary colon and rectal cancer patients that radioimmunoguided surgery (RIGS) technology may provide the most benefit. RIGS is an intraoperative procedure for detection of carcinoma lesions that are targeted with a radiolabeled monoclonal antibody (MAb) to provide the surgeon with immediate intraoperative definition of tumor margins and identification of occult disease. To optimize this technique, our studies were designed to increase tumor uptake by higher affinity CC‐49 (a second‐generation MAb) and to increase tumor antigen expression using biological response modifiers (BRMs). The ability of BRMs, such as interferons (IFNs), to enhance the expression of tumor‐associated antigens, may play an important role in an adjuvant setting for MAb‐based treatment. Preclinical and clinical data provided evidence for the use of IFN as an adjuvant to enhance MAb‐targeting of human carcinoma lesions. A combination protocol with IFN and RIGS is ongoing at our institution. Semin. Surg. Oncol. 15:254–262, 1998.Keywords
This publication has 23 references indexed in Scilit:
- Radioimmunoguided Surgery for Gastrointestinal Malignancies: An Analysis of 14 Years of Clinical ExperienceCancer Control, 1997
- Extended lymph node dissection in gastrointestinal cancerJournal of Surgical Oncology, 1997
- Radioimmunoguided surgery system improves survival for patients with recurrent colorectal cancerSurgery, 1995
- Radioimmunoguided surgery in primary colorectal carcinoma: An intraoperative prognostic tool and adjuvant to traditional stagingThe American Journal of Surgery, 1995
- The significance of intraoperative periportal lymph node metastasis identification in patients with colorectal carcinomaCancer, 1995
- It's time to stop the pendulumJournal of Surgical Oncology, 1994
- Localization of tumor-reactive lymph node lymphocytes in vivo using radiolabeled monoclonal antibodyCancer, 1994
- Intraoperative Detection of Colorectal Cancer With Radioimmunoguided Surgery and CC49, a Second-generation Monoclonal AntibodyAnnals of Surgery, 1992
- Immunohistochemical evidence of immune responses to tumor-associated antigens in lymph nodes of colon carcinoma patientsCancer, 1991
- Radioimmunoguided Surgery Using Iodine 125 B72.3 in Patients With Colorectal CancerArchives of Surgery, 1991